Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Metastasis
Interventions: DRUG: Eribulina
Sponsor: MedSIR